Ig Gene Rearrangement Steps Are Initiated in Early Human Precursor B Cell Subsets and Correlate with Specific Transcription Factor Expression1

The role of specific transcription factors in the initiation and regulation of Ig gene rearrangements has been studied extensively in mouse models, but data on normal human precursor B cell differentiation are limited. We purified five human precursor B cell subsets, and assessed and quantified their IGH, IGK, and IGL gene rearrangement patterns and gene expression profiles. Pro-B cells already massively initiate DH-JH rearrangements, which are completed with VH-DJH rearrangements in pre-B-I cells. Large cycling pre-B-II cells are selected for in-frame IGH gene rearrangements. The first IGK/IGL gene rearrangements were initiated in pre-B-I cells, but their frequency increased enormously in small pre-B-II cells, and in-frame selection was found in immature B cells. Transcripts of the RAG1 and RAG2 genes and earlier defined transcription factors, such as E2A, early B cell factor, E2-2, PAX5, and IRF4, were specifically up-regulated at stages undergoing Ig gene rearrangements. Based on the combined Ig gene rearrangement status and gene expression profiles of consecutive precursor B cell subsets, we identified 16 candidate genes involved in initiation and/or regulation of Ig gene rearrangements. These analyses provide new insights into early human precursor B cell differentiation steps and represent an excellent template for studies on oncogenic transformation in precursor B acute lymphoblastic leukemia and B cell differentiation blocks in primary Ab deficiencies.

[1]  Sean D. Taverna,et al.  Antigen receptor loci poised for V(D)J rearrangement are broadly associated with BRG1 and flanked by peaks of histone H3 dimethylated at lysine 4 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[3]  Harinder Singh,et al.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. , 2003, Genes & development.

[4]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[5]  J. Choi,et al.  E47 activates the Ig‐heavy chain and TdT loci in non‐B cells. , 1996, The EMBO journal.

[6]  J. Inazawa,et al.  Pax-5 Is Essential for κ Sterile Transcription during Igκ Chain Gene Rearrangement1 , 2004, The Journal of Immunology.

[7]  M. Busslinger,et al.  Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. , 1997, Genes & development.

[8]  S. Dudoit,et al.  Resampling-based multiple testing for microarray data analysis , 2003 .

[9]  D. Baltimore,et al.  Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. , 1991, Genes & development.

[10]  J. Gabert,et al.  Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects , 2003, Leukemia.

[11]  M. Busslinger.  Transcriptional control of early B cell development. , 2004, Annual review of immunology.

[12]  Thomas Seidl,et al.  Changes in gene expression profiles in developing B cells of murine bone marrow. , 2002, Genome research.

[13]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[14]  M. Sigvardsson,et al.  EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. , 1997, Immunity.

[15]  L. Herzenberg,et al.  Identification of a germ-line pro-B cell subset that distinguishes the fetal/neonatal from the adult B cell development pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. van der Burg,et al.  Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. , 2001, Blood.

[17]  A. Rolink,et al.  B-cell development: a comparison between mouse and man. , 1998, Immunology today.

[18]  C. V. D. Schoot,et al.  Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia , 2000, Leukemia.

[19]  A. Feeney,et al.  E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. , 2000, Molecular cell.

[20]  D. Schatz,et al.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. , 1990, Science.

[21]  A. Rolink,et al.  Ordering of Human Bone Marrow B Lymphocyte Precursors by Single-Cell Polymerase Chain Reaction Analyses of the Rearrangement Status of the Immunoglobulin H and L Chain Gene Loci , 1996, The Journal of experimental medicine.

[22]  N. Muthusamy,et al.  Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC , 2002, Genes, chromosomes & cancer.

[23]  D. V. van Gent,et al.  Stimulation of V(D)J cleavage by high mobility group proteins , 1997, The EMBO journal.

[24]  S. Nagulapalli.  PU.1Recruits a SecondNuclear Factor toa Site Important for Immunoglobulin K 3'Enhancer Activity , 1992 .

[25]  M. Klemsz,et al.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity , 1992, Molecular and cellular biology.

[26]  M. Schlissel,et al.  A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. , 2003, Immunity.

[27]  C. Murre,et al.  Ets proteins: new factors that regulate immunoglobulin heavy-chain gene expression , 1993, Molecular and cellular biology.

[28]  J. Miguel,et al.  Immunoglobulin lambda isotype gene rearrangements in B cell malignancies , 2001, Leukemia.

[29]  H. Hooijkaas,et al.  Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease , 1997, Leukemia.

[30]  S. Weiss,et al.  B cells are programmed to activate κ and λ for rearrangement at consecutive developmental stages , 1999 .

[31]  V. Velden,et al.  Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin , 2003, Leukemia.

[32]  C. V. D. Schoot,et al.  Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR , 2002, Leukemia.

[33]  M. Farrar,et al.  STAT5 Activation Underlies IL7 Receptor-Dependent B Cell Development1 , 2004, The Journal of Immunology.

[34]  D. Tenen,et al.  Defective B cell receptor‐mediated responses in mice lacking the Ets protein, Spi‐B , 1997, The EMBO journal.

[35]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[36]  R. Hendriks,et al.  Composition of Precursor B-Cell Compartment in Bone Marrow from Patients with X-Linked Agammaglobulinemia Compared with Healthy Children , 2002, Pediatric Research.

[37]  B. Chait,et al.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement , 2003, Nature Immunology.

[38]  F. Watzinger,et al.  Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program , 2003, Leukemia.

[39]  R. Doty,et al.  Regulation of T-cell receptor D beta 1 promoter by KLF5 through reiterated GC-rich motifs. , 2003, Blood.

[40]  Fritz Melchers,et al.  A genomic view of lymphocyte development. , 2003, Current opinion in immunology.

[41]  Christina A. Cuomo,et al.  Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps , 1995, Cell.

[42]  S. Bilke,et al.  Early B-Cell Factor, E2A, and Pax-5 Cooperate To Activate the Early B Cell-Specific mb-1 Promoter , 2002, Molecular and Cellular Biology.

[43]  M. Sigvardsson,et al.  The B29 (Immunoglobulin β-Chain) Gene Is a Genetic Target for Early B-Cell Factor , 1999, Molecular and Cellular Biology.

[44]  D. H. Mellor,et al.  Real time , 1981 .

[45]  M. Busslinger,et al.  Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. , 2004, Genes & development.

[46]  S. Korsmeyer,et al.  A uniform deleting element mediates the loss of κ genes in human B cells , 1985, Nature.

[47]  C. V. D. Schoot,et al.  Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes , 1998, Leukemia.

[48]  Lai-Chu Wu,et al.  The κB transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study , 2002, BMC Immunology.

[49]  U. Grawunder,et al.  How to make ends meet in V(D)J recombination. , 2001, Current opinion in immunology.

[50]  M J T Reinders,et al.  DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers , 2003, Leukemia.

[51]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[52]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.